Home
Home
About
Contact
Begin your search of the AGOSR Open Access Database
Search
Reset
All Fields
Contributors
DOI
OAI
Results: 1
View Article
A latent variable model for improving inference in trials assessing the effect of dose on toxicity and composite efficacy endpoints.
James MS Wason
,
Shaun R Seaman
Feb 12, 2019
It is often of interest to explore how dose affects the toxicity and efficacy properties of a novel treatment. In oncology, efficacy is often assessed through response, which is defined by a patient having no new tumour lesions...
Augmented binary method
Composite endpoints
efficacy/toxicity
phase I/II
Antineoplastic Agents
Clinical Trials
Phase I as Topic
Clinical Trials
Phase II as Topic
Dose-Response Relationship
Drug
Humans
Medical Oncology
Neoplasms
Quinazolines
Randomized Controlled Trials as Topic
Published by: